Evaluation of institutional readiness at sites within the UK NHS using a novel advanced therapy medicinal product assessment tool

Author:

Wotherspoon Lisa1ORCID,Buchan Ruaridh2ORCID,Morrison Ewan3,Amatt Greg4

Affiliation:

1. Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, EH16 4UU, UK

2. Pharmacy, NHS Lothian, Western General Hospital, Edinburgh, EH4 2XU, UK

3. Clinical Directorate, NHS National Services Scotland, Edinburgh, EH12 9EB, UK

4. Special Care and Rare Diseases, Chiesi Ltd, Manchester Green, Manchester, M22 5LG, UK

Abstract

Aim: This paper reports on a study to assess institutional readiness (IR) of UK National Health Service sites that form part of the Northern Alliance Advanced Therapy Treatment Centre to deliver advanced therapy medicinal products (ATMPs). The paper discusses the development of an assessment tool to support self-assessment of IR in healthcare institutions. Methods: The tool utilized criteria developed by clinicians to self-assess IR to deliver four classes of ATMP over a series of time points. Each assessment was independently analyzed and validated by independent expert groups. Results & conclusion: The collated results indicated an overall trend toward IR for all classes of ATMP. The study highlighted areas where IR is evidenced, areas where work is ongoing and areas where further work is required to achieve IR. The study also facilitated validation of the IR assessment tool.

Publisher

Future Medicine Ltd

Subject

Embryology,Biomedical Engineering

Reference30 articles.

1. Anticipating the clinical adoption of regenerative medicine: building institutional readiness in the UK

2. Aligning technology and institutional readiness: the adoption of innovation

3. US FDA. Vaccines, blood and biologicals, cellular and gene therapy products. (2019). https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products

4. EMA. Advanced therapy medicinal products: overview (2020). https://www.ema.europa.eu/en/human-regulatory/overview/advanced-therapy-medicinal-products-overview

5. Cell and Gene Therapy Catapult. News Hub, Press Release: Annual Review (2020). https://ct.catapult.org.uk/news-media/general-news/press-release-annual-review-2020-highlights-impact-growth-and-productivity-0

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3